Buscar
Mostrando ítems 11-20 de 235
Colinesterasas eritrocitaria y plasmática en trabajadores con enfermedades crónicas controladas y en usuarios de medicamentosErythrocytic and plasmatic cholinesrerases in workers with chronic controlled diseases and in users of medicinesColinesterasas en enfermos y en usuarios de medicamentos
(Universidad de Antioquia, Facultad de MedicinaGrupo MalariaMedellín, Colombia, 2021)
Synthesis and cholinesterase inhibition of cativic acid derivatives
(Elsevier, 2014-06)
Alzheimer’s disease (AD) is a neurodegenerative disorder associated with memory impairment and cognitive deficit. Most of the drugs currently available for the treatment of AD are acetylcholinesterase (AChE) inhibitors. ...
Design and microwave-assisted synthesis of aza-resveratrol analogues with potent cholinesterase inhibition
(Bentham Science Publishers, 2020-09)
Currently approved Alzheimer’s disease medications mainly comprise acetylcholinesterase inhibitors. Many of these inhibitors are either natural compounds or synthetic molecules inspired in natural compounds. Hybrids molecules ...
Natural multi-target inhibitors of cholinesterases and monoamine oxidase enzymes with antioxidant potential from skin extracts of Hypsiboas cordobae and Pseudis minuta (Anura: Hylidae)
(Wiley VCH Verlag, 2018-11)
Alzheimer´s disease (AD) is the most common cause of dementia, characterized by loss of selective neuronal and normal brain functions. Every year, ten million new cases are diagnosed worldwide. AD is a complex disease ...
The innate immunity in alzheimer disease-relevance to pathogenesis and therapy
(Bentham Science Publishers B.V., 2015)
Design, synthesis and evaluation of cholinesterase hybrid inhibitors using a natural steroidal alkaloid as precursor
(Academic Press Inc Elsevier Science, 2021-06-11)
To date, Alzheimers disease is the most alarming neurodegenerative disorder worldwide. This illness is multifactorialin nature and cholinesterase inhibitors have been the ones used in clinical treatments. In this context,many ...